Results 211 to 220 of about 152,792 (340)

Myocardial preservation with propofol is dose-dependent [PDF]

open access: bronze, 2005
David M. Ansley   +2 more
openalex   +1 more source

Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.

open access: yesOncology Report, 2017
Cheng Yang   +6 more
semanticscholar   +1 more source

Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Stereotactic body radiation therapy (SBRT) has become a non‐invasive alternative option for canine adrenal tumours with high surgical risks; however, its clinical benefits and risks are still to be fully understood. The goal of this multi‐institutional retrospective study was to describe the clinical outcome and safety of SBRT for the ...
Lily Thorsen   +9 more
wiley   +1 more source

Inadvertent Epidural Injection of Cefazolin in a Dog

open access: yesJournal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To report a case of inadvertent epidural injection of cefazolin in a dog. Case Summary A 5‐year‐old neutered male mixed‐breed dog weighing 37.2 kg was presented to The Ohio State University Veterinary Medical Center's emergency room after the inadvertent epidural administration of cefazolin.
Jessie Warhoe, Jiwoong Her, Turi Aarnes
wiley   +1 more source

Vision outcomes in dogs with primary glaucoma surgically treated with lensectomy and endolaser cyclophotocoagulation after an Ahmed valve gonioimplantation failure

open access: yesVeterinary Ophthalmology, Volume 28, Issue 2, Page 207-217, March 2025.
Abstract Objective The aim of this study was to retrospectively evaluate vision outcomes of dogs with primary angle closure glaucoma (PACG) that underwent Ahmed valve gonioimplantation (AVG) followed by lensectomy and endolaser cyclophotocoagulation (ECP) with or without bleb resection after AVG failure.
Bactelius Turicea   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy